article Open AccessTop 1% cited
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
JNCI Journal of the National Cancer Institute · 2014 · Vol. 106(5)
Nadia Howlader✉(Louisiana State University Health Sciences Center New Orleans)Sean F. Altekruse(Louisiana State University Health Sciences Center New Orleans)Christopher I. Li(National Cancer Institute)Vivien W. Chen(Louisiana State University Health Sciences Center New Orleans)Christina A. Clarke(University of Washington)Lynn A. G. Ries(University of Washington)Kathleen A. Cronin(Cancer Prevention Institute of California)
Abstract
In the future, SEER data can be used to monitor clinical outcomes in women diagnosed with different molecular subtypes of breast cancer for a large portion (approximately 28%) of the US population.
Breast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCancer Risks and FactorsBreast cancerMedicineInternal medicineOncologyEstrogen receptorIncidence (geometry)CancerPopulationHormone receptorEpidemiology
MeSH terms
AgedBlack or African AmericanBreast NeoplasmsFemaleHumansMiddle AgedReceptors, EstrogenReceptors, ProgesteroneRegistriesUnited StatesIncidenceSEER ProgramReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesBlack People
Funding
- National Institutes of Health
- National Cancer Institute
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
Citations
1,461
FWCI
22.75
field-weighted impact
References
36
Percentile
100%
vs. same field & year
Citations per year
Cited by
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Science Translational Medicine · 2015 · 1,115 citations
Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review
Cancers · 2021 · 1,723 citations
Cancer health disparities in racial/ethnic minorities in the United States
British Journal of Cancer · 2020 · 879 citations
Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences
Drugs · 2020 · 404 citations
Breast Cancer Treatment
JAMA · 2019 · 4,716 citations
References
Geocoding and Monitoring of US Socioeconomic Inequalities in Mortality and Cancer Incidence: Does the Choice of Area-based Measure and Geographic Level Matter?: The Public Health Disparities Geocoding Project
American Journal of Epidemiology · 2002 · 1,178 citations
Molecular portraits of human breast tumours
Nature · 2000 · 16,173 citations
Epidemiology of basal-like breast cancer
Breast Cancer Research and Treatment · 2007 · 892 citations
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
Journal of Clinical Oncology · 2010 · 4,231 citations
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
Clinical Cancer Research · 2007 · 2,107 citations
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
JAMA · 2006 · 3,808 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.